Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
Saved in:
| Title: | Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. |
|---|---|
| Authors: | Rubbert-Roth, Andrea1 (AUTHOR) andrea.rubbert-roth@kssg.ch, Kakehasi, Adriana M.2 (AUTHOR), Takeuchi, Tsutomu3,4 (AUTHOR), Schmalzing, Marc5 (AUTHOR), Palac, Hannah6 (AUTHOR), Coombs, Derek6 (AUTHOR), Liu, Jianzhong6 (AUTHOR), Anyanwu, Samuel I.6 (AUTHOR), Lippe, Ralph7 (AUTHOR), Curtis, Jeffrey R.8 (AUTHOR) |
| Source: | Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p97-112. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21986576 |
|---|---|
| DOI: | 10.1007/s40744-023-00621-6 |
